NLRP3 and depressive symptom measurement: Research has found that regulating the HIF-1 signaling pathway can improve LPS-induced depressive behavior59, and CPSP with comorbid anxiety and depression can be improved by increasing cerebral blood flow and inhibiting HIF-1α/NLRP3 inflammatory signaling60.